ImportRefusal LogoImportRefusal

Beijing Novartis Pharma Ltd.

⚠️ Moderate Risk

FEI: 3005085848 • Beijing, Beijing • CHINA

FEI

FEI Number

3005085848

📍

Location

Beijing, Beijing

🇨🇳

Country

CHINA
🏢

Address

Yong'An Road, No. 31 Nanguan, Beijing, Beijing, China

Moderate Risk

FDA Import Risk Assessment

34.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

1
Total Refusals
2
Unique Violations
8/19/2020
Latest Refusal
8/19/2020
Earliest Refusal

Score Breakdown

Violation Severity
75.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

2231×

FALSE

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose labeling appears to be false or misleading.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
8/19/2020
65PDG02SILDENAFIL CITRATE (REGULATOR)
223FALSE
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Beijing Novartis Pharma Ltd.'s FDA import refusal history?

Beijing Novartis Pharma Ltd. (FEI: 3005085848) has 1 FDA import refusal record(s) in our database, spanning from 8/19/2020 to 8/19/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Beijing Novartis Pharma Ltd.'s FEI number is 3005085848.

What types of violations has Beijing Novartis Pharma Ltd. received?

Beijing Novartis Pharma Ltd. has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Beijing Novartis Pharma Ltd. come from?

All FDA import refusal data for Beijing Novartis Pharma Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.